Top Markets
Coin of the day
PharmAust Limited PharmAust Limited

PharmAust Limited

PAA
Classificação em ações #26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Preço da ação
$0.12164306
Última sincronização: 2024-11-11
Valor de mercado
$38.53M
Variação (1 dia)
-4.14%
Variação (1 ano)
0.00%
País
AU
Negociar PharmAust Limited (PAA)

Categoria

Lucros da PharmAust Limited (PAA)
Lucros em Jun 2024 TTM: $-6.31M
De acordo com os últimos relatórios financeiros da PharmAust Limited, os ganhos atuais da empresa são de $-6.31M. Em 2023, a empresa teve ganhos de $-4.14M, uma diminuição em relação a aos ganhos de 2022, que foram de $-1.18M. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da PharmAust Limited de 2001 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-6.31M 0.00%
2024 $-6.31M 52.51%
2023 $-4.14M 251.26%
2022 $-1.18M 17.50%
2021 $-1.00M 6.70%
2020 $-939.77K -13.74%
2019 $-1.09M -41.67%
2018 $-1.87M 80.51%
2017 $-1.03M -64.63%
2016 $-2.93M 97.39%
2015 $-1.48M 19.24%
2014 $-1.24M 112.82%
2013 $-584.08K -86.59%
2012 $-4.35M -29.96%
2011 $-6.22M 1,573.65%
2010 $-371.45K 155.62%
2009 $-145.32K -97.37%
2008 $-5.53M -0.89%
2007 $-5.58M 173.13%
2006 $-2.04M -20.13%
2005 $-2.56M 42.56%
2004 $-1.80M 29.13%
2003 $-1.39M -33.40%
2002 $-2.09M 96.03%
2001 $-1.06M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$5.27B -83,669.91%
US
$1.95B -31,004.03%
NL
$1.61B -25,675.00%
AU
$-3.09B 48,807.15%
US
- -
CH